Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$0.2 - $0.5 $9,720 - $24,300
-48,600 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$0.41 - $0.63 $396 - $608
-966 Reduced 1.95%
48,600 $27,000
Q4 2021

Feb 14, 2022

SELL
$0.57 - $1.29 $2,395 - $5,421
-4,203 Reduced 7.82%
49,566 $29,000
Q3 2021

Nov 15, 2021

BUY
$1.11 - $1.7 $11,893 - $18,215
10,715 Added 24.89%
53,769 $66,000
Q2 2021

Aug 17, 2021

BUY
$1.46 - $2.25 $62,858 - $96,871
43,054 New
43,054 $73,000
Q1 2019

May 15, 2019

SELL
$0.51 - $1.88 $9,666 - $35,633
-18,954 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$0.39 - $3.47 $7,392 - $65,770
18,954 New
18,954 $8,000

About TREVENA INC


  • Ticker TRVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 173,680,992
  • Market Cap $273M
  • Description
  • Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...
More about TRVN
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.